Arian Pano

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact for Arian Pano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arian Pano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals, Ltd. Chief Clinical Dev. Officer Share Option 23.3K Sep 2, 2021 Direct
Kiniksa Pharmaceuticals, Ltd. Chief Clinical Dev. Officer Restricted Share Units 3.89K Sep 2, 2021 Direct

Insider Reports Filed by Arian Pano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 Chief Clinical Dev. Officer
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 10, 2021 0 $0 3 Jun 21, 2021 Chief Clinical Dev. Officer